Roby Chen China

Humanwell is the market leader in anaesthetics/analgesics, fertility regulation drugs, and Uyghur medicine in Asia. It is also a major player with expanding product portfolio and market shares in treating central nerve system, respiratory and dermatological diseases in China.
Company Size (Fulltime employees)
Year of foundation
1993
Please specify your partnering goal
See above
Headquartner in China
Humanwell Healthcare
投资部经理 

Denise Chen China

GIG, one of the leading healthcare investment institute, was founded in Shenzhen in 2001. AUM is RMB ¥20b. It has invested in 80+ healthcare companies. 22 went IPO. GIG has 90+ staff in team with operating offices in Shenzhen, Shanghai, Beijing, Nanjing and Hongkong.

Website:
www.szgig.com
Company Size (Fulltime employees)
Please specify your partnering goal
potential investing targets and collaborations
Headquartner in China
Medtech Development Stage
GIG
Partner 
Functionality

Dr. Kai Chen United States

MID Labs has been associated with vitreoretinal surgery from its infancy. Not only has MID Labs invented the tools for modern vitrectomy, but as a company, we have been instrumental in revolutionizing the ophthalmic field through our products.

MID Labs continues to innovate with the MID Labs branded product line which is supplied to more than 30 countries around the world. These products set the standard for precision, performance, and quality.
Website:
midlabs.com
Company Size (Fulltime employees)
Year of foundation
30
Partnering Objectives
Please specify your partnering goal
marketing partner
Headquartner in China
Medtech Category
Medtech Information 1
Vitrectomy cutter||
Medtech Development Stage
MID LABS
CEO 
Functionality

Anita Chen

L.E.K. Consulting is a global strategy consulting firm that specializes in corporate strategy, transaction services, and performance improvement. Founded in 1983, we now have more than 1,500 professionals located across major economies worldwide. Clients include Fortune 500, FTSE 100, Eurotop 300, and many of the largest firms in Asia-Pacific.

 

With a reputation for solving the most complex issues, L.E.K. collaborates closely with business leaders and their teams to accelerate the pace and precision of strategic decision-making. L.E.K. works across numerous industry sectors including a strong focus on the healthcare sector.

 

As a leading strategic advisor to the life sciences industry, L.E.K.’s clients include the largest and most advanced pharmaceutical, biotech, medical devices, tools and diagnostics companies. L.E.K.’s global team of life sciences professionals has expertise across all major industry segments and therapeutic areas, and we provide support at each stage of the product life cycle, from drug discovery to commercial optimisation.

 

L.E.K. hosts the Asia Pacific Life Sciences Centre of Excellence in partnership with the Singapore Economic Development Board (“EDB”). This Centre of Excellence (“CoE”) drives thought leadership and innovation to elevate the life sciences ecosystem both in Singapore and across the region.

Website:
www.lek.com
L.E.K. Consulting

Guofeng Cheng China

Biotech
Partnering Objectives
Headquartner in China
Biotech/Pharma Category
AusperBio
CEO 

Mr. Xinwei Cheng United States

Drug delivery antibody gene
Website:
www.luye.com
Company Size (Fulltime employees)
Year of foundation
2012
Partnering Objectives
Please specify your partnering goal
Looking for science and service
Headquartner in China
Luye Boston
Senior Scientists 
Functionality

Mr. Cliff Cheng China

A pharmaceutical company
Website:
www.buchang.com
Company Size (Fulltime employees)
Please specify your partnering goal
licensing-in and partnership
Headquartner in China
Buchang Pharma Group
CSO 

Wei Cheng

Public trade pharmaceutical company
Website:
Www.Fibrogen.com
Partnering Objectives
Headquartner in China
Fibrogen
Executive director 

Changfu Cheng United States

Dear Prospect Customer:

I would like to introduce my company (TDM Pharmaceutical Research, Inc) to you. TDM Pharmaceutical Research, INC, is a highly productive, intensely focused, quality-oriented CRO; we are experienced, well established, and driven by scientific merit. As a full-service GLP and GCP compliant laboratory, TDM offers a variety of discovery, research, development, bioanalytical, and consulting services to support discovery and development of pharmaceutical and chemical products. We pride ourselves on prompt data turnaround and addressing our clients’ needs with the accuracy and quality that are critical to their businesses.

TDM is uniquely different from other CROs: our over 90 years of combined industry experience allows us to resolve complex issues by providing comprehensive solutions in pharmacokinetics, toxicokinetics, pharmacokinetic/pharmacodynamic correlations, and more.

We are experienced in both the sponsor and the CRO position, so we anticipate and address the needs of our clients. Resourceful, committed personnel provide proactive support throughout each project, and respond to potential issues immediately.

Our myriad clients include both companies and individuals in the pharmaceutical and related industries. By selecting TDM as the partner for your next project, you will find we take each job and its needs personally; our focus is always on the client!

If you have any question, please feel free to contact me at: changfu.cheng@tdmrxresearch.com, or phone at 1-774-258-2425.

Thanks!

 

Changfu Cheng, PhD

President

TDM Pharmaceutical Research, Inc

https://tdmpharmalab.com

Company Size (Fulltime employees)
Year of foundation
1996
Please specify your partnering goal
IND of our drug candidates
Headquartner in China
Biotech/Pharma Category
Assets Information 1
FLUORINE- AND/OR DEUTERIUM-CONTAINING COMPOUNDS FOR TREATING NON-SMALL CELL LUNG CANCER AND RELATED DISEASES, US patent 10,633,367
Assets Information 2
DEUTERATED COMPOUNDS FOR TREATING FABRY, GAUCHER, PARKINSON’S AND RELATED DISEASES AND CONDITIONS, AND COMPOSITIONS AND METHODS THEREOF. US patent 10,519,157
Biotech/Pharma Asset Stage
Slides Deck
(pdf, 802.42KB)
TMD Pharmaceutical Research
President 
Functionality

Haipeng Cheng China

Sangel Capital provides venture capital and business finance to support high-tech enterprises in China and US. The firm seeks to invest in innovative startups in sectors including biopharma, diagnostics, medical devices, and biotech.
Sangel Capital was founded in 2010 and is based in Shenzhen, Beijing with additional offices in Suzhou and Chicago.
Sangel Capital